2018-2023 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Report
- LP 2648645
- 136 Pages
- July 2018
- Pharmaceuticals
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.
The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015.
Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Over the next five years, LPI(LP Information) projects that Glucagon Like Peptide-1 (GLP-1) Agonists will register a 14.3% CAGR in terms of revenue, reach US$ 11700 million by 2023, from US$ 5240 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon Like Peptide-1 (GLP-1) Agonists market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide
Segmentation by application:
Hospital
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Glucagon Like Peptide-1 (GLP-1) Agonists consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Glucagon Like Peptide-1 (GLP-1) Agonists market by identifying its various subsegments.
Focuses on the key global Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Glucagon Like Peptide-1 (GLP-1) Agonists with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Glucagon Like Peptide-1 (GLP-1) Agonists submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2013-2023
2.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption CAGR by Region
2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
2.2.1 Exenatied
2.2.2 Liraglutide
2.2.3 Lixisenatide
2.2.4 Albiglutide
2.2.5 Dulaglutide
2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type
2.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
2.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2013-2018)
2.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Type (2013-2018)
2.4 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
2.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
2.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Value and Market Share by Application (2013-2018)
2.5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Application (2013-2018)
3 Global Glucagon Like Peptide-1 (GLP-1) Agonists by Players
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players
3.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Players (2016-2018)
3.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players (2016-2018)
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players
3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Players (2016-2018)
3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players (2016-2018)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Players
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Glucagon Like Peptide-1 (GLP-1) Agonists by Regions
4.1 Glucagon Like Peptide-1 (GLP-1) Agonists by Regions
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Regions
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Value by Regions
4.2 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth
4.3 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth
4.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth
4.5 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth
5 Americas
5.1 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries
5.1.1 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018)
5.1.2 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018)
5.2 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type
5.3 Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries
6.1.1 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018)
6.1.2 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018)
6.2 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type
6.3 APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists by Countries
7.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018)
7.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018)
7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type
7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists by Countries
8.1.1 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018)
8.2 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type
8.3 Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
10.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customer
11 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast
11.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast (2018-2023)
11.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecast by Regions
11.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecast by Regions (2018-2023)
11.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecast by Type
11.8 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Company Details
12.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Novo Nordisk News
12.2 AstraZeneca
12.2.1 Company Details
12.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 AstraZeneca News
12.3 Eli Lilly
12.3.1 Company Details
12.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.3.3 Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Eli Lilly News
12.4 GSK
12.4.1 Company Details
12.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 GSK News
12.5 Sanofi
12.5.1 Company Details
12.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Sanofi News
12.6 Bristol-Myers Squibb
12.6.1 Company Details
12.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Bristol-Myers Squibb News
12.7 Amylin
12.7.1 Company Details
12.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
12.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Amylin News
...
13 Research Findings and Conclusion
Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Report Years Considered
Figure Market Research Methodology
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate 2013-2023 (K Units)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth Rate 2013-2023 ($ Millions)
Table Glucagon Like Peptide-1 (GLP-1) Agonists Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Exenatied
Table Major Players of Exenatied
Figure Product Picture of Liraglutide
Table Major Players of Liraglutide
Figure Product Picture of Lixisenatide
Table Major Players of Lixisenatide
Figure Product Picture of Albiglutide
Table Major Players of Albiglutide
Figure Product Picture of Dulaglutide
Table Major Players of Dulaglutide
Table Global Consumption Sales by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2013-2018) ($ million)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Type (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Type (2013-2018)
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Consumed in Hospital
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Hospital (2013-2018) (K Units)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Consumed in Pharmacy
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Pharmacy (2013-2018) (K Units)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Pharmacy (2013-2018) ($ Millions)
Figure Global Pharmacy YoY Growth ($ Millions)
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Consumed in Other
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Other (2013-2018) (K Units)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Application (2013-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Application (2013-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Players (2016-2018) (K Units)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players (2016-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players in 2016
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Players in 2017
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Players (2016-2018) ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players (2016-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players in 2016
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Players in 2017
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Players (2016-2018)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Players in 2017
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Sales Area by Players
Table Players Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
Table Glucagon Like Peptide-1 (GLP-1) Agonists Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Regions 2013-2018 (K Units)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Regions 2013-2018
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Regions 2013-2018
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value by Regions 2013-2018 ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Regions 2013-2018
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Regions 2013-2018
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2013-2018 (K Units)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value 2013-2018 ($ Millions)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2013-2018 (K Units)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value 2013-2018 ($ Millions)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2013-2018 (K Units)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value 2013-2018 ($ Millions)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2013-2018 (K Units)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value 2013-2018 ($ Millions)
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018) (K Units)
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries (2013-2018)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2017
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018) ($ Millions)
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries (2013-2018)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries in 2017
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type (2013-2018) (K Units)
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type in 2017
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application (2013-2018) (K Units)
Table Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2017
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018) (K Units)
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries (2013-2018)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2017
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018) ($ Millions)
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries (2013-2018)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries in 2017
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type (2013-2018) (K Units)
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type in 2017
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application (2013-2018) (K Units)
Table APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2017
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Korea Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Korea Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Australia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Australia Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018) (K Units)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries (2013-2018)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2017
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018) ($ Millions)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries (2013-2018)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries in 2017
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type (2013-2018) (K Units)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type in 2017
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application (2013-2018) (K Units)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2017
Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Countries in 2017
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share by Countries in 2017
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Type in 2017
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2017
Figure Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Israel Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Israel Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth 2013-2018 ($ Millions)
Table Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table Glucagon Like Peptide-1 (GLP-1) Agonists Customer List
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Forecast by Regions
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share Forecast by Regions
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Americas Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure APAC Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Canada Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Korea Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Korea Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Australia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Australia Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Spain Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Israel Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Israel Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Consumption 2018-2023 (K Units)
Figure GCC Countries Glucagon Like Peptide-1 (GLP-1) Agonists Value 2018-2023 ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Type (2018-2023) (K Units)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share Forecast by Type (2018-2023)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Forecast by Type (2018-2023) ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share Forecast by Type (2018-2023)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2018-2023) (K Units)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share Forecast by Application (2018-2023)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Forecast by Application (2018-2023) ($ Millions)
Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Value Market Share Forecast by Application (2018-2023)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Table Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2016-2018)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
